Drummond experts can help you prepare
The Drug Enforcement Administration (DEA) has announced the electronic prescribing of controlled substances (EPCS) Interim Final Rule will be finalized next month. The DEA regulations for EPCS outlined in 21 CFR 1311 have been in interim status since they were published in March 2010.
Based on a request for comment posted by the DEA in June 2020, the DEA is evaluating the current two-factor authentication technologies, practices for identity proofing doctors, security practices and auditing criteria. These changes will impact all EHR vendors who support the electronic prescribing of controlled substances.
10 years of EPCS expertise
This past August, Drummond celebrated its 10th anniversary of the DEA’s approval of our certification process for auditing EPCS applications. Please visit the DEA website which recognizes Drummond as one of their approved certification processes.
With DEA EPCS Final Rule changes coming in the regulatory landscape, you need an experienced and reliable EPCS auditor to help guide you. Drummond is the foremost expert on EPCS regulations and has certified hundreds of prescriber and pharmacy applications. Our experts are standing by to help you understand the new DEA requirements once they are announced and guide you in their implementation.
Want to learn more about Drummond EPCS?
Contact Aaron Gomez, Supply Chain Security Business Unit Leader via sales@drummondgroup.com. Or if you wish to have a special consultation, please register here.